AstraZeneca has vowed to spend over $10 billion on R&D deals in Asia, focusing on China, amid ongoing fraud scandal investigations.

Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.

As we observe Endometriosis Awareness Month in March, let us take a look at 7 biotech companies advancing promising ...

The first RIPTAC has just hit the clinic. Learn about this new technology that is being developed by Halda Therapeutics.

Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...

As AbbVie accuses Genmab of unlawfully using proprietary ADC technology, find out about their collaboration and the dispute ...

Learn how AI-driven TechBio is revolutionizing biotech in our exclusive interview with Bullfrog AI CEO Vin Singh.

According to the World Health Organization (WHO), breast cancer was the most common cancer in women in 157 countries out of 185 in 2022, with incidence rates found to be rising by 1% per year overall ...